P14

By Targets:	Apoptosis (3) BMI1 (1) Neurokinin Receptor (1) PI3K (1) Small Interfering RNA (siRNA) (11)
By Research Areas:	Cancer (5)
Oligonucleotides:	小干扰RNA (11) 小干扰RNA套装（小鼠） (3) 小干扰RNA套装（大鼠） (1) 小干扰RNA套装（人源） (7)

Cat. No.	Product Name	Target	Research Area	Chemical Structure

HY-P3598

*Substance P(1-4)*	Neurokinin Receptor	Cancer
Substance P(1-4) 是一种有效的神经激肽受体(NK-R)拮抗剂。Substance P(1-4) 对正常造血有调节作用，抑制内源性红细胞集落 (EEC) 的形成。

HY-RS12212

RPP14 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
RPP14 Human Pre-designed siRNA Set A 包括针对 RPP14 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

RPP14 Human Pre-designed siRNA Set A RPP14 Human Pre-designed siRNA Set A

HY-164536

SLCB050	Apoptosis	Cancer
SLCB050 是一种可以阻断 DX2 和 p14/ARF 之间的相互作用的化合物，具有抗癌活性。SLCB050 以 p14/ARF 依赖的方式降低人肺癌细胞，特别是小细胞肺癌细胞的活力，并诱导的细胞凋亡 (apoptosis) 和衰老。

HY-RS13999

SUB1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
SUB1 Human Pre-designed siRNA Set A 包括针对 SUB1 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

SUB1 Human Pre-designed siRNA Set A SUB1 Human Pre-designed siRNA Set A

HY-RS02379

CDK2AP2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
CDK2AP2 Human Pre-designed siRNA Set A 包括针对 CDK2AP2 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

CDK2AP2 Human Pre-designed siRNA Set A CDK2AP2 Human Pre-designed siRNA Set A

HY-N0992

1,6,7-Trihydroxyxanthone	BMI1 Apoptosis	Cancer
1,6,7-三羟基呫吨酮 1,6,7-Trihydroxyxanthone 是一种有效的抗癌剂。1,6,7-Trihydroxyxanthone 抑制细胞增殖并诱导细胞细胞凋亡 (Apoptosis)。1,6,7-Trihydroxyxanthone 降低 Bmi-1 的表达，增加 P14，P16 的蛋白表达水平。

HY-145338

PI3Kβ-IN-1	PI3K	Cancer
PI3Kβ-IN-1 (化合物 (P)-14) 是一种选择性和具有口服活性的 PI3Kβ 抑制剂，IC₅₀ 值为 2 nM。

HY-RS10164

Pcolce Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Pcolce Mouse Pre-designed siRNA Set A 包括针对 Pcolce (Mouse) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

Pcolce Mouse Pre-designed siRNA Set A Pcolce Mouse Pre-designed siRNA Set A

HY-RS19544

Lamtor2 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Lamtor2 Mouse Pre-designed siRNA Set A 包括针对 Lamtor2 (Mouse) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

Lamtor2 Mouse Pre-designed siRNA Set A Lamtor2 Mouse Pre-designed siRNA Set A

HY-RS23706

Fabp1 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Fabp1 Rat Pre-designed siRNA Set A 包括针对 Fabp1 (Rat) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

Fabp1 Rat Pre-designed siRNA Set A Fabp1 Rat Pre-designed siRNA Set A

HY-RS07514

LAMTOR2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
LAMTOR2 Human Pre-designed siRNA Set A 包括针对 LAMTOR2 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

LAMTOR2 Human Pre-designed siRNA Set A LAMTOR2 Human Pre-designed siRNA Set A

HY-RS16579

S100a9 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
S100a9 Mouse Pre-designed siRNA Set A 包括针对 S100a9 (Mouse) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

S100a9 Mouse Pre-designed siRNA Set A S100a9 Mouse Pre-designed siRNA Set A

HY-RS12765

SF3B6 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
SF3B6 Human Pre-designed siRNA Set A 包括针对 SF3B6 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

SF3B6 Human Pre-designed siRNA Set A SF3B6 Human Pre-designed siRNA Set A

HY-RS12386

S100A9 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
S100A9 Human Pre-designed siRNA Set A 包括针对 S100A9 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

S100A9 Human Pre-designed siRNA Set A S100A9 Human Pre-designed siRNA Set A

HY-RS02414

CDKN2A Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
CDKN2A Human Pre-designed siRNA Set A 包括针对 CDKN2A (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

CDKN2A Human Pre-designed siRNA Set A CDKN2A Human Pre-designed siRNA Set A

HY-P10553

ARF(26–44), cell-permeable	Apoptosis	Cancer
ARF(26–44), cell-permeable 是一种抗肿瘤肽，来源于 p14ARF 肿瘤抑制蛋白的特定氨基酸序列。ARF(26–44) cell-permeable 作为 FoxM1 (一种叉头框 M1 转录因子) 的功能抑制剂，在小鼠肝细胞癌 (HCC) 治疗中显示出了显著的抗肿瘤活性，能够显著增加肿瘤细胞的凋亡 (apoptosis) 以及减少肿瘤细胞增殖和血管生成。ARF(26–44), cell-permeable 可用于肿瘤治疗的研究。

Cat. No.	Product Name	Target	Research Area

HY-P3598

*Substance P(1-4)*	Neurokinin Receptor	Cancer
Substance P(1-4) 是一种有效的神经激肽受体(NK-R)拮抗剂。Substance P(1-4) 对正常造血有调节作用，抑制内源性红细胞集落 (EEC) 的形成。

HY-P10553

ARF(26–44), cell-permeable	Apoptosis	Cancer
ARF(26–44), cell-permeable 是一种抗肿瘤肽，来源于 p14ARF 肿瘤抑制蛋白的特定氨基酸序列。ARF(26–44) cell-permeable 作为 FoxM1 (一种叉头框 M1 转录因子) 的功能抑制剂，在小鼠肝细胞癌 (HCC) 治疗中显示出了显著的抗肿瘤活性，能够显著增加肿瘤细胞的凋亡 (apoptosis) 以及减少肿瘤细胞增殖和血管生成。ARF(26–44), cell-permeable 可用于肿瘤治疗的研究。

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N0992

1,6,7-Trihydroxyxanthone	Structural Classification Natural Products Goodyera oblongifolia Raf. Orchidaceae Source classification Plants	BMI1 Apoptosis
1,6,7-三羟基呫吨酮 1,6,7-Trihydroxyxanthone 是一种有效的抗癌剂。1,6,7-Trihydroxyxanthone 抑制细胞增殖并诱导细胞细胞凋亡 (Apoptosis)。1,6,7-Trihydroxyxanthone 降低 Bmi-1 的表达，增加 P14，P16 的蛋白表达水平。

Species:	Human (3) Cynomolgus (1) Canine (1)
Tag:	His (4) Tag Free (1)
Source:	E. coli (5)

Cat. No.	Compare	Product Name	Species	Source

HY-P74650

	PC4/SUB1 Protein, Human (His) Activated RNA polymerase II transcriptional coactivator p15; PC4; P14; SUB1; RPO2TC1	Human	E. coli
	PC4 蛋白/SUB1 蛋白 PC4/SUB1 蛋白充当多功能共激活剂，与 TAF 配合促进上游激活剂和一般转录机制之间的功能相互作用。它的作用延伸到多蛋白转录复合物的潜在稳定性。PC4/SUB1 Protein, Human (His) 是重组的 PC4/SUB1 蛋白，由 E. coli 表达，带有 N-His 标签。

HY-P72785

	CDKN2A Protein, Human Cyclin-dependent kinase inhibitor 2A; CDK4I; MTS-1; p16INK4A	Human	E. coli
	CDKN2A 蛋白 CDKN2A 蛋白是细胞增殖的有效负调节因子，与 CDK4 和 CDK6 形成强烈的相互作用，阻碍它们与细胞周期蛋白 D 和视网膜母细胞瘤蛋白磷酸化的关联。CDKN2A 以异二聚体方式（主要与 CDK6 一起作用）抑制细胞周期蛋白 D-CDK4 激酶活性并与 ISCO2 相互作用，从而发挥其细胞周期调节作用。CDKN2A Protein, Human 是重组的 CDKN2A 蛋白，由 E. coli 表达，不带标签。

HY-P77830

	S100A9 Protein, Canine (His) S100-A9; Calgranulin-B; Calprotectin L1H subunit; MRP-14; P14; CAGB; MRP14	Canine	E. coli
	S100A9 蛋白 S100A9 蛋白是一种钙和锌结合剂，在炎症和免疫反应中发挥着关键的调节作用。其多种功能包括诱导中性粒细胞趋化、粘附、通过 SYK、PI3K/AKT 和 ERK1/2 激活增强杀菌活性以及促进吞噬作用。S100A9 Protein, Canine (His) 是重组的 S100A9 蛋白，由 E. coli 表达，带有 N-His 标签。

HY-P70372

	Ribonuclease UK114/HRSP12 Protein, Human (His) rHuRibonuclease UK114/HRSP12, His; Ribonuclease UK114; 14.5 kDa Translational Inhibitor Protein; P14.5; Heat-Responsive Protein 12; UK114 Antigen Homolog; HRSP12; PSP	Human	E. coli
	Ribonuclease UK114 蛋白/HRSP12 蛋白核糖核酸酶 UK114/HRSP12 蛋白催化烯胺/亚胺中间体的水解脱氨，通过释放氨来降低这些反应性代谢物的潜在毒性。Ribonuclease UK114/HRSP12 Protein, Human (His) 是重组的核糖核酸酶 UK114/HRSP12 蛋白，由 E. coli 表达，带有 N-6*His 标签。

HY-P77829

	S100A9 Protein, Cynomolgus (His) S100-A9; Calgranulin-B; Calprotectin L1H subunit; MRP-14; P14; CAGB; MRP14	Cynomolgus	E. coli
	S100A9 蛋白 S100A9 蛋白是一种钙和锌结合剂，在炎症和免疫反应中发挥着关键的调节作用。其多种功能包括诱导中性粒细胞趋化、粘附、通过 SYK、PI3K/AKT 和 ERK1/2 激活增强杀菌活性以及促进吞噬作用。S100A9 Protein, Cynomolgus (His) 是重组的 S100A9 蛋白，由 E. coli 表达，带有 N-His 标签。

产品对比


产品	In-stock - + Add to Cart
货号
种属
表达系统
标签
蛋白编号
基因 ID
分子量
纯度
内毒素含量
生物活性
性状
组分
保存条件 & 期限
运输条件
Free Sample	Yes No
规格	*该产品已“停产”。等效替代： / In-stock - + Add to Cart 询价

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P80615

	CDKN2A/p16INK4a Antibody (YA508) CDK4 inhibitor p16 INK4 antibody; CDK4I antibody; CDKN2 antibody; CDKN2A antibody; Cell cycle negative regulator beta antibody; CMM2 antibody; Cyclin dependent kinase 4 inhibitor A antibody; Cyclin dependent kinase inhibitor 2A (melanoma p16 inhibits CDK4) antibody; Cyclin Dependent Kinase Inhibitor 2A antibody; Cyclin dependent kinase inhibitor 2A isoform 4 antibody; Cyclin dependent kinase inhibitor 2A isoforms 1/2/3 antibody; Cyclin dependent kinase inhibitor p16 antibody; INK4 antibody; INK4A antibody; MLM antibody; MTS1 antibody; Multiple tumor suppressor 1 antibody; P14 antibody; p16 antibody; P16INK4 antibody; p16INK4a antibody; p19 antibody; p19Arf antibody; TP16 antibody	WB, IP	Human, Mouse
	CDKN2A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to CDKN2A. It can be used for WB,IP assays with tag free, in the background of Human, Mouse.

HY-P83734

	S100A9 Antibody(YA3464) Leukocyte L1 complex heavy chain antibody; 60B8AG antibody; CAGB antibody; Calgranulin B antibody; Calgranulin-B antibody; Calprotectin L1H subunit antibody; CFAG antibody; CGLB antibody; Cystic fibrosis antigen B antibody; L1AG antibody; Leukocyte L1 complex heavy chain antibody; LIAG antibody; MAC387 antibody; MIF antibody; Migration inhibitory factor related protein 14 antibody; Migration inhibitory factor-related protein 14 antibody; MRP 14 antibody; MRP-14 antibody; MRP14 antibody; Myeloid-related protein 14 antibody; NIF antibody; OTTHUMP00000015331 antibody; P14 antibody; Protein S100-A9 antibody; S100 A9 antibody; S100 calcium binding protein A9 antibody; S100 calcium binding protein A9 calgranulin B antibody; S100 calcium-binding protein A9 antibody; S100A9 antibody; S10A9_HUMAN antibody;	WB, IHC-P, IF-Tissue, mIHC	Human
	S100A9 Antibody(YA3464) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA3464), targeting S100A8. S100A9 Antibody (YA1170) can be used for WB, IHC-P, mIHC, IF-Tissue experiment in human background.

HY-P85309

	p14ARF Antibody (YA5001) CDKN2A; CDKN2; MLM; Cyclin-dependent kinase inhibitor 2A; isoform 4; P14ARF; p19ARF	WB, IHC-P, ICC/IF, ELISA	Human, Mouse, Rat

HY-P86609

	p14ARF Antibody (YA6301) CDKN2A; CDKN2; MLM; Cyclin-dependent kinase inhibitor 2A; isoform 4; P14ARF; p19ARF	WB, ICC/IF, IP, ELISA	Human

HY-P85928

	TCL1 Antibody (YA5620) Anti TCL1A; Lymphoma/leukemia, T-cell; Oncogene TCL-1; Oncogene TCL1; P14 TCL1; P14 TCL1 protein; Protein P14 TCL1; T cell leukemia 1; T cell lymphoma 1; T cell lymphoma 1A; T-cell leukemia/lymphoma 1A; T-cell leukemia/lymphoma protein 1A; TCL 1 protein; TCL1; TCL1 oncogene; TCL1 PEN; Tcl1a; TCL1A; TCL1A_HUMAN	IHC-P, WB, ICC/IF, ELISA	Human

HY-P83974

	S100A9 Antibody (YA3671) MIF; NIF; P14; CAGB; CFAG; CGLB; L1AG; LIAG; MRP14; 60B8AG; MAC387	IHC-P, FC, ELISA	Human

HY-P81959

	T Cell Leukemia/Lymphoma Protein 1A Antibody (YA1704) Anti TCL1A; P14 TCL1; T cell leukemia 1; TCL1; TCL1 PEN; Tcl1a	WB, IHC-P, ICC/IF, FC	Human
	T Cell Leukemia/Lymphoma Protein 1A Antibody (YA1704) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1704), targeting T Cell Leukemia/Lymphoma Protein 1A, with a predicted molecular weight of 13 kDa (observed band size: 13 kDa). T Cell Leukemia/Lymphoma Protein 1A Antibody (YA1704) can be used for WB, IHC-P, ICC/IF, FC experiment in human background.

HY-P84321

	CDKN2A Antibody (YA4018) ARF; MLM; P14; P16; P19; CMM2; INK4; MTS1; TP16; CDK4I; CDKN2; INK4A; MTS-1; P14ARF; P19ARF; P16INK4; P16INK4A; P16-INK4A	WB, IHC-P, FC, ELISA	Human

HY-P80615A

	CDKN2A/p16INK4a Antibody (YA508)(PBS only) CDK4 inhibitor p16 INK4 antibody; CDK4I antibody; CDKN2 antibody; CDKN2A antibody; Cell cycle negative regulator beta antibody; CMM2 antibody; Cyclin dependent kinase 4 inhibitor A antibody; Cyclin dependent kinase inhibitor 2A (melanoma p16 inhibits CDK4) antibody; Cyclin Dependent Kinase Inhibitor 2A antibody; Cyclin dependent kinase inhibitor 2A isoform 4 antibody; Cyclin dependent kinase inhibitor 2A isoforms 1/2/3 antibody; Cyclin dependent kinase inhibitor p16 antibody; INK4 antibody; INK4A antibody; MLM antibody; MTS1 antibody; Multiple tumor suppressor 1 antibody; P14 antibody; p16 antibody; P16INK4 antibody; p16INK4a antibody; p19 antibody; p19Arf antibody; TP16 antibody;	WB, IP	Human, Mouse
	CDKN2A Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 17 kDa, targeting to CDKN2A. It can be used for WB,IP assays with tag free, in the background of Human, Mouse.

HY-P81818

	*CDKN2A/p14ARF Antibody (YA1563)* CDKN2A; CDKN2; MLM; Alternative reading frame （ARF）; Cyclin-dependent kinase inhibitor 2A; P14arf	WB, ICC/IF, IP, FC	Human
	CDKN2A/p14ARF Antibody (YA1563) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA1563), targeting CDKN2A/p14ARF, with a predicted molecular weight of 14 kDa (observed band size: 14 kDa). CDKN2A/p14ARF Antibody (YA1563) can be used for WB, ICC/IF, IP, FC experiment in human background.

HY-P82258

	SMYD3 Antibody (YA2003) KMT3E; ZMYND1; ZNFN3A1; bA74P14.1	WB, IHC-F, IHC-P, ICC/IF, IP	Human
	SMYD3 Antibody (YA2003) is a rabbit-derived non-conjugated IgG antibody (Clone NO.: YA2003), targeting SMYD3, with a predicted molecular weight of 49 kDa (observed band size: 49 kDa). SMYD3 Antibody (YA2003) can be used for WB, IHC-F, IHC-P, ICC/IF, IP experiment in human background.

HY-P84695

	CTNNBL1 Antibody (YA4392) NAP; P14L; PP8304; C20orf33; dJ633O20.1	WB, IHC-P, ICC/IF, FC, ELISA	Human

产品对比


产品	In-stock - + Add to Cart
货号
宿主
反应物种
应用
推荐稀释比例
分子量
偶联
克隆性
免疫原
性状
同型
基因 ID
蛋白数据库
纯度
组分
Free Sample	Yes No
规格	*该产品已“停产”。等效替代： / In-stock - + Add to Cart 询价

Cat. No.	Product Name		Classification

HY-RS12212

RPP14 Human Pre-designed siRNA Set A		小干扰RNA 小干扰RNA套装（人源）
RPP14 Human Pre-designed siRNA Set A 包括针对 RPP14 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

HY-RS13999

SUB1 Human Pre-designed siRNA Set A		小干扰RNA 小干扰RNA套装（人源）
SUB1 Human Pre-designed siRNA Set A 包括针对 SUB1 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

HY-RS02379

CDK2AP2 Human Pre-designed siRNA Set A		小干扰RNA 小干扰RNA套装（人源）
CDK2AP2 Human Pre-designed siRNA Set A 包括针对 CDK2AP2 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

HY-RS10164

Pcolce Mouse Pre-designed siRNA Set A		小干扰RNA 小干扰RNA套装（小鼠）
Pcolce Mouse Pre-designed siRNA Set A 包括针对 Pcolce (Mouse) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

HY-RS19544

Lamtor2 Mouse Pre-designed siRNA Set A		小干扰RNA 小干扰RNA套装（小鼠）
Lamtor2 Mouse Pre-designed siRNA Set A 包括针对 Lamtor2 (Mouse) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

HY-RS23706

Fabp1 Rat Pre-designed siRNA Set A		小干扰RNA 小干扰RNA套装（大鼠）
Fabp1 Rat Pre-designed siRNA Set A 包括针对 Fabp1 (Rat) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

HY-RS07514

LAMTOR2 Human Pre-designed siRNA Set A		小干扰RNA 小干扰RNA套装（人源）
LAMTOR2 Human Pre-designed siRNA Set A 包括针对 LAMTOR2 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

HY-RS16579

S100a9 Mouse Pre-designed siRNA Set A		小干扰RNA 小干扰RNA套装（小鼠）
S100a9 Mouse Pre-designed siRNA Set A 包括针对 S100a9 (Mouse) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

HY-RS12765

SF3B6 Human Pre-designed siRNA Set A		小干扰RNA 小干扰RNA套装（人源）
SF3B6 Human Pre-designed siRNA Set A 包括针对 SF3B6 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

HY-RS12386

S100A9 Human Pre-designed siRNA Set A		小干扰RNA 小干扰RNA套装（人源）
S100A9 Human Pre-designed siRNA Set A 包括针对 S100A9 (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

HY-RS02414

CDKN2A Human Pre-designed siRNA Set A		小干扰RNA 小干扰RNA套装（人源）
CDKN2A Human Pre-designed siRNA Set A 包括针对 CDKN2A (Human) 基因的不同区域设计三对 siRNA，以及阴性对照、FAM 标记阴性对照和阳性对照。

* 客户姓名：			* 公司或机构名称：
* Email：			* 联系电话：
* 产品名称：			* 需求量：
目录号：			CAS号：
留言给我们：

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2025 MedChemExpress. All Rights Reserved.

抑制剂 & 激动剂

多肽产品

天然产物

重组蛋白

抗体

寡核苷酸

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z